PLAVIX: payments to doctors
Payments that named PLAVIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $137K
- Providers
- 14
- Transactions
- 46
- Average per transaction
- $2,980
The per-transaction average — $2,980 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 14 providers the average total is $9,792, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $136,954 | 99.9% |
| Bristol Myers Squibb | $139 | 0.1% |